Press release
Global Genotyping Market Size Worth USD 38.7 Billion By 2030 | CAGR 12.5%: Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1233
Market Overview and Projections
The Genotyping Market, valued at USD 13.3 billion in 2022, is anticipated to surge to USD 38.7 billion by 2030, exhibiting a robust Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period from 2023 to 2030.
Unlocking the Genetic Code: Advancements in Genotyping
Genotyping involves the analysis of an individual's genetic material, such as DNA, to identify specific genetic variations or markers. Utilizing techniques like PCR, DNA sequencing, and microarray analysis, it assists in determining an individual's genetic makeup, offering insights into disease predisposition, medication response, ancestry, and trait associations. The applications span across medicine, genetics research, agriculture, forensics, and population genetics, enabling breakthroughs in disease understanding, targeted therapies, and agricultural advancements.
Drivers and Contributions to Market Growth
The rising incidence of genetic diseases like cancer, diabetes, and tuberculosis significantly propels the genotyping market forward. Genotyping plays a pivotal role in comprehending the genetic factors associated with these diseases, leading to enhanced disease management, personalized treatments, and precise interventions. Moreover, its crucial role in the pharmaceutical industry, fostering the need for more effective treatments and personalized medicine, continues to drive market growth, prompting increased research and development in the sector.
Challenges and Technological Advancements
While stringent regulations and unfavorable reimbursement practices pose limitations, technological advancements in genotyping, especially through DNA microarray technology, promise significant market growth. The deployment of advanced genotyping technologies enhances resolution and accuracy, revolutionizing the field.
Regional Dynamics and Market Segments
North America is poised to dominate the Genotyping Market, supported by advanced healthcare infrastructure, robust R&D activities, and increased adoption of personalized medicine. Conversely, the Asia Pacific region emerges as the fastest-growing market, driven by a burgeoning population and a rising prevalence of genetic diseases, amplifying the need for genotyping technologies.
Detailed Segments Covered in the Report
The report segments the global Genotyping Market based on product (instruments, reagents & kits, bioinformatics, software, and services), technology (PCR, microarrays, sequencing, etc.), application (pharmacogenomics, diagnostics, personalized medicine, etc.), and end-use (pharmaceutical companies, diagnostics labs, academic institutes, etc.).
Profiles of Key Market Players
The report encompasses detailed profiles of industry leaders such as Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Fluidigm (now Standard BioTools), Danaher, Agilent Technologies, Inc., Eurofins Scientific, GE HealthCare, and BGI Group, shedding light on their strategies and market positioning.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1233
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Genotyping Market Highlights
2.2. Genotyping Market Projection
2.3. Genotyping Market Regional Highlights
Chapter 3. Global Genotyping Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product
3.4.2. IGR-Growth Matrix Analysis by Technology
3.4.3. IGR-Growth Matrix Analysis by Application
3.4.4. IGR-Growth Matrix Analysis by End-use
3.4.5. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Genotyping Market
Chapter 4. Genotyping Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Genotyping Market
5.2. Companies Profiles
5.2.1. Illumina, Inc.
5.2.2. Thermo Fisher Scientific Inc.
5.2.3. QIAGEN
5.2.4. F. Hoffmann-La Roche Ltd
5.2.5. Fluidigm (is now Standard BioTools)
5.2.6. Danaher
5.2.7. Agilent Technologies, Inc.
5.2.8. Eurofins Scientific
5.2.9. GE HealthCare
5.2.10. BGI Group
Chapter 6. Global Genotyping Market by Product
6.1. Instruments
6.2. Reagents & Kits
6.3. Bioinformatics
6.4. Software and Services
Chapter 7. Global Genotyping Market by Technology
7.1. PCR
7.2. Capillary Electrophoresis
7.3. Microarrays
7.4. MALDI-TOF
7.5. Sequencing
7.6. Mass Spectrometry
7.7. Others
Chapter 8. Global Genotyping Market by Application
8.1. Pharmacogenomics
8.2. Diagnostics
8.3. Personalized Medicine
8.4. Agricultural Biotechnology
8.5. Animal Genetic
8.6. Others
Chapter 9. Global Genotyping Market by End-use
9.1. Pharmaceutical and Biopharmaceutical Companies
9.2. Diagnostics and Research Laboratories
9.3. Academic Institutes
9.4. Others
Chapter 10. Global Genotyping Market by Region 2023-2030
10.1. North America
10.1.1. North America Genotyping Market by Product
10.1.2. North America Genotyping Market by Technology
10.1.3. North America Genotyping Market by Application
10.1.4. North America Genotyping Market by End-use
10.1.5. North America Genotyping Market by Country
10.1.5.1. The U.S. Genotyping Market
10.1.5.1.1. The U.S. Genotyping Market by Product
10.1.5.1.2. The U.S. Genotyping Market by Technology
10.1.5.1.3. The U.S. Genotyping Market by Application
10.1.5.1.4. The U.S. Genotyping Market by End-use
10.1.5.2. Canada Genotyping Market
10.1.5.2.1. Canada Genotyping Market by Product
10.1.5.2.2. Canada Genotyping Market by Technology
10.1.5.2.3. Canada Genotyping Market by Application
10.1.5.2.4. Canada Genotyping Market by End-use
10.1.5.3. Mexico Genotyping Market
10.1.5.3.1. Mexico Genotyping Market by Product
10.1.5.3.2. Mexico Genotyping Market by Technology
10.1.5.3.3. Mexico Genotyping Market by Application
10.1.5.3.4. Mexico Genotyping Market by End-use
10.2. Europe
10.2.1. Europe Genotyping Market by Product
10.2.2. Europe Genotyping Market by Technology
10.2.3. Europe Genotyping Market by Application
10.2.4. Europe Genotyping Market by End-use
10.2.5. Europe Genotyping Market by Country
10.2.5.1. Germany Genotyping Market
10.2.5.1.1. Germany Genotyping Market by Product
10.2.5.1.2. Germany Genotyping Market by Technology
10.2.5.1.3. Germany Genotyping Market by Application
10.2.5.1.4. Germany Genotyping Market by End-use
10.2.5.2. United Kingdom Genotyping Market
10.2.5.2.1. United Kingdom Genotyping Market by Product
10.2.5.2.2. United Kingdom Genotyping Market by Technology
10.2.5.2.3. United Kingdom Genotyping Market by Application
10.2.5.2.4. United Kingdom Genotyping Market by End-use
10.2.5.3. France Genotyping Market
10.2.5.3.1. France Genotyping Market by Product
10.2.5.3.2. France Genotyping Market by Technology
10.2.5.3.3. France Genotyping Market by Application
10.2.5.3.4. France Genotyping Market by End-use
10.2.5.4. Italy Genotyping Market
10.2.5.4.1. Italy Genotyping Market by Product
10.2.5.4.2. Italy Genotyping Market by Technology
10.2.5.4.3. Italy Genotyping Market by Application
10.2.5.4.4. Italy Genotyping Market by End-use
10.2.5.5. Rest of Europe Genotyping Market
10.2.5.5.1. Rest of Europe Genotyping Market by Product
10.2.5.5.2. Rest of Europe Genotyping Market by Technology
10.2.5.5.3. Rest of Europe Genotyping Market by Application
10.2.5.5.4. Rest of Europe Genotyping Market by End-use
10.3. Asia Pacific
10.3.1. Asia Pacific Genotyping Market by Product
10.3.2. Asia Pacific Genotyping Market by Technology
10.3.3. Asia Pacific Genotyping Market by Application
10.3.4. Asia Pacific Genotyping Market by End-use
10.3.5. Asia Pacific Genotyping Market by Country
10.3.5.1. China Genotyping Market
10.3.5.1.1. China Genotyping Market by Product
10.3.5.1.2. China Genotyping Market by Technology
10.3.5.1.3. China Genotyping Market by Application
10.3.5.1.4. China Genotyping Market by End-use
10.3.5.2. Japan Genotyping Market
10.3.5.2.1. Japan Genotyping Market by Product
10.3.5.2.2. Japan Genotyping Market by Technology
10.3.5.2.3. Japan Genotyping Market by Application
10.3.5.2.4. Japan Genotyping Market by End-use
10.3.5.3. India Genotyping Market
10.3.5.3.1. India Genotyping Market by Product
10.3.5.3.2. India Genotyping Market by Technology
10.3.5.3.3. India Genotyping Market by Application
10.3.5.3.4. India Genotyping Market by End-use
10.3.5.4. South Korea Genotyping Market
10.3.5.4.1. South Korea Genotyping Market by Product
10.3.5.4.2. South Korea Genotyping Market by Technology
10.3.5.4.3. South Korea Genotyping Market by Application
10.3.5.4.4. South Korea Genotyping Market by End-use
10.3.5.5. Australia Genotyping Market
10.3.5.5.1. Australia Genotyping Market by Product
10.3.5.5.2. Australia Genotyping Market by Technology
10.3.5.5.3. Australia Genotyping Market by Application
10.3.5.5.4. Australia Genotyping Market by End-use
10.3.5.6. Rest of Asia-Pacific Genotyping Market
10.3.5.6.1. Rest of Asia-Pacific Genotyping Market by Product
10.3.5.6.2. Rest of Asia-Pacific Genotyping Market by Technology
10.3.5.6.3. Rest of Asia-Pacific Genotyping Market by Application
10.3.5.6.4. Rest of Asia-Pacific Genotyping Market by End-use
10.4. RoW
10.4.1. RoW Genotyping Market by Product
10.4.2. RoW Genotyping Market by Technology
10.4.3. RoW Genotyping Market by Application
10.4.4. RoW Genotyping Market by End-use
10.4.5. RoW Genotyping Market by Sub-region
10.4.5.1. Latin America Genotyping Market
10.4.5.1.1. Latin America Genotyping Market by Product
10.4.5.1.2. Latin America Genotyping Market by Technology
10.4.5.1.3. Latin America Genotyping Market by Application
10.4.5.1.4. Latin America Genotyping Market by End-use
10.4.5.2. Middle East Genotyping Market
10.4.5.2.1. Middle East Genotyping Market by Product
10.4.5.2.2. Middle East Genotyping Market by Technology
10.4.5.2.3. Middle East Genotyping Market by Application
10.4.5.2.4. Middle East Genotyping Market by End-use
10.4.5.3. Africa Genotyping Market
10.4.5.3.1. Africa Genotyping Market by Product
10.4.5.3.2. Africa Genotyping Market by Technology
10.4.5.3.3. Africa Genotyping Market by Application
10.4.5.3.4. Africa Genotyping Market by End-use
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1233
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of Genotyping.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Genotyping Market Size Worth USD 38.7 Billion By 2030 | CAGR 12.5%: Infinium Global Research here
News-ID: 3302402 • Views: …
More Releases from Infinium Global Research LLP
Infinium Global Research LLP Launches Comprehensive Service to Assist Foreign Co …
Pune, India - October 26, 2024 - Infinium Global Research LLP is excited to announce the launch of a dedicated service aimed at providing end-to-end support for foreign companies entering or expanding within the Indian market. With a strategic network of partnerships with top legal and consulting firms and increased presence across key Indian cities, Infinium is well-equipped to facilitate smooth market entry, operational setup, and business expansion for international…
Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends.
The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections.
To Know More Request a Sample of…
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surp …
Infinium Global Research introduces a detailed analysis of the global and regional Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) market, providing an extensive study of its segments, trends, forecasts, and dollar values in their latest report. This comprehensive study empowers stakeholders in the pharmaceutical and healthcare sectors with invaluable insights into this burgeoning market.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420
Market Insight:
The global Proprotein Convertase Subtilisin/Kexin Type 9 market,…
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93
Market Insight:
The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast…
More Releases for Genotyping
Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Genotyping Assay Market Size Growth Forecast: What to Expect by 2025?
In recent times, the genotyping assay market has witnessed significant expansion. The market value is projected to rise from $33.98 billion in 2024 to $41.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.4%. Factors…
The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Genotyping Market Size By 2025?
The market size for genotyping has seen a swift expansion in the recent past. Its growth will continue to accelerate from $23.04 billion in 2024, reaching $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The…
Top Factor Driving Genotyping Market Growth in 2025: The Surge In Cancer And Gen …
How Are the key drivers contributing to the expansion of the genotyping market?
The escalating occurrence of cancer and genetic abnormalities is anticipated to drive the genotyping market's expansion. A myriad of diseases falling under the broad term 'cancer' can originate from virtually any tissue or organ in the body. Genetic disorders, meanwhile, are conditions that are completely or largely caused by deviations in the normal DNA sequence. Genotyping enables researchers…
Genotyping Assay Market worth $37.1 billion by 2029
The major players in this market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US)
The global genotyping assay market [https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr], valued at US$17.4 billion in 2023, is forecasted to grow at a robust CAGR of 13.8%, reaching US$19.4 billion in 2024 and an impressive US$37.1 billion by 2029. This growth is driven by…
Genotyping Market Outlook and Major Regions' Development Status
The Genotyping Market report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Genotyping Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100001166?utm_source=OpenPR&utm_medium=10791
Key Players Analysis:
Hoffmann-La Roche Ltd.
Integrated DNA Technologies, Inc.
QIAGEN
MERCK KGaA
Eurofins Genomics
Thermo Fisher Scientific Inc
BioTek Instruments, Inc.
Xcelris Genomics
TrimGen Corporation
Illumina, Inc.
The report covers key developments in the Genotyping…
Single Nucleotide Polymorphisms Genotyping Market - Unraveling Genetic Codes, Un …
Newark, New Castle, USA - new report, titled Single Nucleotide Polymorphisms Genotyping Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Single Nucleotide Polymorphisms Genotyping market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Single Nucleotide Polymorphisms Genotyping market. The report offers…
